Insights into novel diagnostic assay development, antimicrobial resistance, and pathogenicity in Proteus mirabilis through pan-genome analysis
Applied and Environmental Microbiology · 2026
DOI: 10.1128/aem.01898-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied and Environmental Microbiology, 2026. Verfasst von Zhiqiu Yin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institu…. Hauptthemen laut MEDLINE: Genome, Bacterial, Anti-Bacterial Agents, Proteus mirabilis, Drug Resistance, Multiple, Bacterial. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Guangdong Basic and Applied Basic Research Foundation: Provincial-Enterprise Joint Fund, Engineering Technology Research (Development) Center of Ordinary Colleges and Universities in Guangdong Province.
Abstract (Originalsprache)
Proteus mirabilis , a significant pathogen associated with human urinary tract infections (UTIs), demonstrates escalating multidrug resistance (MDR) that complicates clinical management. Accurate identification and in-depth genomic analysis are essential for monitoring and controlling this pathogen. This study aimed to identify the species-specific gene repertoire, antimicrobial resistance (AMR), and virulence genetic profiles through pan-genome analysis to develop novel detection methods and better understand emerging public health threats. The genus Proteus exhibits an open pan-genome, with P. mirabilis harboring a distinct species-specific gene repertoire. Two species-specific core genes, PMI3020 and PMI3598 , were identified as molecular targets. We developed conventional PCR and TaqMan probe-based real-time PCR assays, which demonstrated high specificity when tested against P. mirabilis and non- P . mirabilis isolates. The TaqMan probe-based real-time PCR demonstrated a sensitivity of 3.43 × 10² CFU/mL using serial dilutions of P. mirabilis DNA. Comparative genomic analysis revealed significant differences in AMR and pathogenicity-related gene repertoires between P. mirabilis and other Proteus spp. The higher prevalence of AMR phenotypes in P. mirabilis correlated with its greater abundance of AMR genes. Emerging AMR genes acquired through horizontal gene transfer (HGT) have increased MDR risks, particularly to carbapenems and cephalosporins. Additionally, P. mirabilis genomes contain more virulence genes mainly related to adherence and iron acquisition. Our findings establish pan-genome analysis as an effective tool for identifying specific genetic markers to detect pathogens accurately and provide a comprehensive genomic framework illuminating AMR dynamics and virulence in P. mirabilis , thereby providing a valuable foundation for future public health risk assessments. IMPORTANCE P. mirabilis is a major uropathogen with increasing AMR prevalence. The dissemination of AMR genes across healthcare and community settings poses critical challenges to infection control. This study conducted pan-genome analysis of Proteus to identify P. mirabilis -specific gene repertoire, of which species-specific core genes were used as molecular targets to develop highly sensitive PCR assays for accurate detection of this pathogen. Compared with other Proteus spp., P. mirabilis possesses a greater abundance of AMR genes, resulting in a higher prevalence of AMR phenotypes, including significant resistance to carbapenems and cephalosporins. This study establishes pan-genome analysis as an effective strategy for mining species-specific genetic markers, enabling the development of novel PCR assays for accurate pathogen detection. The comprehensive genomic framework enhances understanding of AMR dynamics and virulence mechanisms essential for public health risk assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital, Guangzhou Medical University, Guan…
- KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, Guangdong, China.
- Engineering Technology Research Center of Intelligent Diagnosis for Infectious Diseases in Guangdong Province, Guangzhou, China.
- Guangzhou Key Laboratory for Clinical Rapid Diagnosis and Early Warning of Infectious Diseases, Guangzhou, China.
ORCID-Profile: Zhiqiu Yin, Xiaoyan Deng, Liang Peng
Förderung
- National Key Research and Development Program of China
- Guangdong Basic and Applied Basic Research Foundation: Provincial-Enterprise Joint Fund
- Engineering Technology Research (Development) Center of Ordinary Colleges and Universities in Guangdong Province
- Guangdong Engineering Technology Research Center
- Research Ability Enhancement Program of Guangzhou Medical University
- National College Students Innovation and Entrepreneurship Training Program
- China Postdoctoral Science Foundation
Zitieren
APA
Yin, Z., Chen, X., Xiao, J., Tian, X., Li, Z., Zhang, M., Jing, B., Li, D., Deng, X., & Peng, L. (2026). Insights into novel diagnostic assay development, antimicrobial resistance, and pathogenicity in Proteus mirabilis through pan-genome analysis. Applied and Environmental Microbiology. https://doi.org/10.1128/aem.01898-25
Vancouver
Yin Z, Chen X, Xiao J, Tian X, Li Z, Zhang M, et al. Insights into novel diagnostic assay development, antimicrobial resistance, and pathogenicity in Proteus mirabilis through pan-genome analysis. Applied and Environmental Microbiology. 2026. doi:10.1128/aem.01898-25
BibTeX
@article{Yin2026,
author = {Yin, Zhiqiu and Chen, Xiaman and Xiao, Juncong and Tian, Xiaoyan and Li, Zhuolin and Zhang, Mujie and Jing, Baixin and Li, Dongsheng and Deng, Xiaoyan and Peng, Liang},
title = {Insights into novel diagnostic assay development, antimicrobial resistance, and pathogenicity in Proteus mirabilis through pan-genome analysis},
journal = {Applied and Environmental Microbiology},
year = {2026},
doi = {10.1128/aem.01898-25}
}
EUVIMED